Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
5
RGLXY Quote, Financials, Valuation and Earnings
Last price:
$2.44
Seasonality move
:
5.51%
Day range:
$2.44 - $2.44
52-week range:
$2.44 - $3.84
Dividend yield:
12.07%
P/E ratio:
6.68x
P/S ratio:
0.56x
P/B ratio:
0.89x
Volume:
--
Avg. volume:
294
1-year change:
-32.6%
Market cap:
$3.8B
Revenue:
$6.7B
EPS (TTM):
$0.37
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $7.4B | $6.9B | $7.9B | $6.9B | $6.7B | |
| Revenue Growth (YoY) | -3.07% | -7.71% | 14.28% | -11.51% | -2.88% | |
| Cost of Revenues | $2.6B | $2.4B | $3B | $2.9B | $2.8B | |
| Gross Profit | $4.8B | $4.5B | $4.9B | $4.1B | $3.9B | |
| Gross Profit Margin | 65.12% | 64.87% | 61.79% | 58.8% | 58.31% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $466.8M | $439.7M | $444.9M | $349.1M | $423.3M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $3.6B | $3.6B | $3.6B | $3.2B | $3.3B | |
| Operating Income | $1.2B | $897.6M | $1.3B | $882.7M | $633.3M | |
| Net Interest Expenses | $21.3M | $42.3M | $48.5M | $55.9M | $44.4M | |
| EBT. Incl. Unusual Items | $1.3B | $999.3M | $2.2B | $814.1M | $657.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | $130.8M | $124.5M | |
| Income Tax Expense | $326.9M | $285.5M | $505.2M | $137.1M | $134.2M | |
| Net Income to Company | $1.3B | $999.3M | $2.2B | $982.9M | $814.1M | |
| Minority Interest in Earnings | -$123.1M | -$151.9M | -$181M | -$98.1M | -$141.8M | |
| Net Income to Common Excl Extra Items | $844.1M | $561.9M | $1.5B | $709.7M | $505.6M | |
| Basic EPS (Cont. Ops) | $0.55 | $0.37 | $1.00 | $0.46 | $0.33 | |
| Diluted EPS (Cont. Ops) | $0.55 | $0.37 | $1.00 | $0.46 | $0.33 | |
| Weighted Average Basic Share | $1.5B | $1.5B | $1.5B | $1.5B | $1.5B | |
| Weighted Average Diluted Share | $1.5B | $1.5B | $1.5B | $1.5B | $1.5B | |
| EBITDA | $1.6B | $1.3B | $2.5B | $1.1B | $978.7M | |
| EBIT | $1.3B | $1B | $2.3B | $843.7M | $710.2M | |
| Revenue (Reported) | $7.4B | $6.9B | $7.9B | $6.9B | $6.7B | |
| Operating Income (Reported) | $1.2B | $897.6M | $1.3B | $882.7M | $633.3M | |
| Operating Income (Adjusted) | $1.3B | $1B | $2.3B | $843.7M | $710.2M | |
| Period Ending | 2014-12-31 | 2015-12-31 | 2016-12-31 | 2017-12-31 | 2018-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $2.3B | $2.1B | $2.2B | $2.4B | $2.3B | |
| Revenue Growth (YoY) | -5.73% | -11.17% | 4.82% | 10.03% | -2.44% | |
| Cost of Revenues | $1B | $760.4M | $840.4M | $794.9M | $778.1M | |
| Gross Profit | $1.3B | $1.3B | $1.3B | $1.6B | $1.5B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $744.3M | $827.2M | $867.4M | $1B | $1.1B | |
| Operating Income | $568.3M | $478.1M | $457.4M | $568.8M | $454.1M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $580.7M | $500M | $475.8M | $584.1M | $364M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $113.7M | $114.9M | $138.1M | $175.5M | $39.9M | |
| Net Income to Company | $620.9M | $506M | $481.2M | $530.4M | $390.1M | |
| Minority Interest in Earnings | -$33.7M | -$29.5M | -$38.8M | -$49.5M | -$45.6M | |
| Net Income to Common Excl Extra Items | $433.4M | $355.6M | $298.8M | $359.2M | $278.4M | |
| Basic EPS (Cont. Ops) | $0.28 | $0.23 | $0.20 | $0.23 | $0.18 | |
| Diluted EPS (Cont. Ops) | $0.28 | $0.23 | $0.20 | $0.23 | $0.18 | |
| Weighted Average Basic Share | $1.5B | $1.5B | $1.5B | $1.5B | $1.5B | |
| Weighted Average Diluted Share | $1.5B | $1.5B | $1.5B | $1.5B | $1.5B | |
| EBITDA | $668.2M | $578.8M | $553.4M | $668.9M | $447.3M | |
| EBIT | $589.5M | $508.8M | $483.3M | $592.3M | $370.8M | |
| Revenue (Reported) | $2.3B | $2.1B | $2.2B | $2.4B | $2.3B | |
| Operating Income (Reported) | $568.3M | $478.1M | $457.4M | $568.8M | $454.1M | |
| Operating Income (Adjusted) | $589.5M | $508.8M | $483.3M | $592.3M | $370.8M | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Revenue | $6.8B | $7.6B | $7.6B | $6.5B | $6.8B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $2.4B | $2.8B | $3B | $2.8B | $2.8B | |
| Gross Profit | $4.3B | $4.9B | $4.6B | $3.6B | $3.9B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $3.5B | $3.7B | $3.5B | $3.1B | $3.2B | |
| Operating Income | $877.8M | $1.2B | $1.1B | $563M | $702.1M | |
| Net Interest Expenses | $27.6M | $40.7M | $76.8M | $26.5M | $72.1M | |
| EBT. Incl. Unusual Items | $883.3M | $2.2B | $1.2B | $471.3M | $681.7M | |
| Earnings of Discontinued Ops. | -- | -- | -- | $60M | $132.4M | |
| Income Tax Expense | $245.3M | $531.8M | $313.1M | $41.7M | $126M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -$134.7M | -$164.2M | -$162.3M | -$96.9M | -$123.8M | |
| Net Income to Common Excl Extra Items | $503.3M | $1.5B | $761.9M | $519.4M | $564.3M | |
| Basic EPS (Cont. Ops) | $0.33 | $0.98 | $0.49 | $0.34 | $0.37 | |
| Diluted EPS (Cont. Ops) | $0.33 | $0.98 | $0.49 | $0.34 | $0.37 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | $1.2B | $2.6B | $1.5B | $769.6M | $1B | |
| EBIT | $925.3M | $2.2B | $1.3B | $508.5M | $745.2M | |
| Revenue (Reported) | $6.8B | $7.6B | $7.6B | $6.5B | $6.8B | |
| Operating Income (Reported) | $877.8M | $1.2B | $1.1B | $563M | $702.1M | |
| Operating Income (Adjusted) | $925.3M | $2.2B | $1.3B | $508.5M | $745.2M | |
| Period Ending | 2020-12-23 | 2021-12-23 | 2022-12-23 | 2023-12-23 | ||
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -- | -- | -- | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -- | -- | -- | |
| Basic EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
| Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | -- | -- | -- | -- | -- | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | -- | -- | -- | -- | -- | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $422.3M | $536.3M | $619.3M | $631.6M | $635.6M | |
| Short Term Investments | $32.5M | $698.6M | $1.2B | $438.6M | $205.6M | |
| Accounts Receivable, Net | $1.6B | $1.4B | $1.4B | $1.4B | $1.4B | |
| Inventory | $14.6M | $9.8M | $17M | $19.3M | $9.9M | |
| Prepaid Expenses | $110.9M | $147.6M | $90.6M | $99.7M | $112.8M | |
| Other Current Assets | $1.4B | $1.5B | $1.5B | $1.9B | $2B | |
| Total Current Assets | $4.5B | $5.4B | $6.3B | $5.1B | $5B | |
| Property Plant And Equipment | $778.5M | $762.6M | $619.3M | $658.5M | $582.5M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $3.4B | $3.5B | $3.4B | $3.6B | $3.5B | |
| Other Intangibles | $334.9M | $451.4M | $678.2M | $712.1M | $690.9M | |
| Other Long-Term Assets | $100.8M | -- | -$18.1M | -$10.7M | -$5.5M | |
| Total Assets | $10.1B | $11.2B | $11.9B | $10.9B | $10.7B | |
| Accounts Payable | $1.7B | $1.7B | $1.7B | $1.5B | $1.4B | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $66.1M | $73.8M | $66.8M | $91.2M | $84M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $3.8B | $3.8B | $4.1B | $3.9B | $3.2B | |
| Long-Term Debt | $706.8M | $788.4M | $719M | $148M | $761.6M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $5.8B | $5.8B | $5.9B | $5.3B | $5B | |
| Common Stock | $215.1M | $236.2M | $217.4M | $205.9M | $212.2M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $3.7B | $4.6B | $5.1B | $4.7B | $4.7B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $597.1M | $795.8M | $867.3M | $848.3M | $939.6M | |
| Total Equity | $4.3B | $5.4B | $6B | $5.6B | $5.6B | |
| Total Liabilities and Equity | $10.1B | $11.2B | $11.9B | $10.9B | $10.7B | |
| Cash and Short Terms | $454.8M | $1.2B | $1.9B | $1.1B | $841.2M | |
| Total Debt | $882.7M | $940.9M | $774.4M | $734.6M | $1B | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $575.8M | $398.7M | $529.6M | $487.9M | $490.9M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $2B | $3.6B | $2.1B | $2.1B | $2.5B | |
| Inventory | $16.9M | $15.5M | $28.2M | $15.2M | $12.9M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $1.4B | $1.5B | $1.7B | $1.9B | $1.8B | |
| Total Current Assets | $4B | $5.7B | $4.4B | $4.6B | $5.3B | |
| Property Plant And Equipment | $752.4M | $672.4M | $643.5M | $656.4M | $571.3M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $3.5B | $3.4B | $3.5B | $3.6B | $3.6B | |
| Other Intangibles | $365.5M | $487.9M | $576.6M | $698.8M | $651.7M | |
| Other Long-Term Assets | -- | -- | -- | $109.8M | $120.1M | |
| Total Assets | $9.6B | $11.3B | $9.9B | $10.4B | $11B | |
| Accounts Payable | $2.4B | $2.8B | $2.1B | $2B | $2.1B | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $70.9M | $65.5M | $85.7M | $97.8M | $83.6M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $3.2B | $3.9B | $3.6B | $3.4B | $4.1B | |
| Long-Term Debt | $711.9M | $761.6M | $145.2M | $794.4M | $735.3M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $5.1B | $5.7B | $4.9B | $5.3B | $5.9B | |
| Common Stock | $215.9M | $228.5M | $200.6M | $208.7M | $205.8M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $673.7M | $746.1M | $756.3M | $848.7M | $883.2M | |
| Total Equity | $4.5B | $5.6B | $5B | $5B | $5.1B | |
| Total Liabilities and Equity | $9.6B | $11.3B | $9.9B | $10.4B | $11B | |
| Cash and Short Terms | $575.8M | $398.7M | $529.6M | $487.9M | $490.9M | |
| Total Debt | $1B | $860.4M | $729.1M | $1.3B | $1.7B | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $1.3B | $999.3M | $2.2B | $982.9M | $814.1M | |
| Depreciation & Amoritzation | $286.6M | $300.4M | $269.8M | $253.1M | $268.5M | |
| Stock-Based Compensation | $9M | $5.7M | $7.1M | $5.3M | $4.3M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $1.2B | $1.1B | $1.1B | $488.3M | $581.4M | |
| Capital Expenditures | $217.2M | $203.3M | $230.7M | $212M | $191.6M | |
| Cash Acquisitions | -$99.6M | $127.9M | $403.5M | $371.2M | $20.6M | |
| Cash From Investing | -$363.8M | -$706.9M | -$134.9M | $693.9M | $28.1M | |
| Dividends Paid (Ex Special Dividend) | -$602.3M | -$4.6M | -$673.2M | -$907M | -$753.5M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $150M | $286.6M | $66.3M | $36.9M | $317.2M | |
| Long-Term Debt Repaid | -$267.6M | -$309.5M | -$133.7M | -$83.3M | -$44.4M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$49.3M | -$71.9M | -$52.1M | -$87.5M | -$15.2M | |
| Cash From Financing | -$863.1M | -$198.7M | -$898M | -$1.2B | -$625.7M | |
| Beginning Cash (CF) | $472.4M | $437.4M | $599.9M | $601.1M | $636.6M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$45.9M | $159.9M | $69.8M | $30.6M | -$16.2M | |
| Ending Cash (CF) | $420.9M | $496.8M | $647.2M | $620.1M | $620.3M | |
| Levered Free Cash Flow | $963.9M | $862.2M | $872M | $276.3M | $389.7M | |
| Period Ending | 2014-12-31 | 2015-12-31 | 2016-12-31 | 2017-12-31 | 2018-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $620.9M | $506M | $481.2M | $530.4M | $390.1M | |
| Depreciation & Amoritzation | $84.4M | $70.8M | $69.4M | $66.5M | $81.9M | |
| Stock-Based Compensation | $9.3M | $2.2M | $3.3M | $3.1M | $2.5M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $664.3M | $556.3M | $526.5M | $703.6M | $540.2M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -$145.5M | -$72.1M | $11.6M | $19.7M | $91.7M | |
| Cash From Investing | -$235.3M | -$84M | -$66.5M | $90.2M | $18.5M | |
| Dividends Paid (Ex Special Dividend) | -$7.6M | -$971.3K | $3.1M | $24.9M | -$13.5M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -$220.1M | -$286.8M | -$198.2M | -$466.5M | -$347.7M | |
| Long-Term Debt Repaid | -$32.2K | $1.1M | -$183.6M | -$262.9M | $63.3M | |
| Repurchase of Common Stock | $7.9M | $1.1M | -- | -- | -- | |
| Other Financing Activities | $2.7M | $1.1M | -$8.8M | -$160.6M | -$17.9M | |
| Cash From Financing | -$217.2M | -$286.6M | -$389.6M | -$865.6M | -$320.8M | |
| Beginning Cash (CF) | $421.4M | $306.7M | $402.9M | $388M | $247.7M | |
| Foreign Exchange Rate Adjustment | $1.3M | $1.1M | $6.7M | -$5.4M | $3.5M | |
| Additions / Reductions | $211.7M | $185.7M | $70.4M | -$71.8M | $237.8M | |
| Ending Cash (CF) | $637M | $492.7M | $477M | $292.2M | $498.3M | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
| Period Ending | 2020-12-23 | 2021-12-23 | 2022-12-23 | 2023-12-23 | ||
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
| Period Ending | 2020-12-23 | 2021-12-23 | 2022-12-23 | 2023-12-23 | ||
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
Get RGLXY Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
RGLXY
Sector
P/E ratio
6.68x
16.53x
PEG ratio
--
0.01x
P/B ratio
0.89x
1.42x
Price / LTM sales
0.56x
0.94x
Growth Metrics
RGLXY
Sector
Revenue growth
--
-0.19%
Earnings growth
--
0.38%
Revenue (5-year growth)
-2.55%
1.77%
Earnings forecast
--
$0.15
Profitability
RGLXY
Sector
Profitability FY 2023
$3.9B
$343.9M
Return on invested capital
8.55%
0.94%
Return on assets
5.28%
0.07%
Return on equity
10.71%
2.62%
Earnings Date
Last Earnings Date
Dec
23
Next Earnings Date
Dec
23
Estimated Next Earnings Date
Mar
24
Balance Sheet
RGLXY
Sector
Total cash
$490.9M
$115M
Short term investments
$205.6M
$67.8M
Total assets
$10.7B
$1B
Long term debt
$1.7B
$54.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
